Baohua Sun

Oct 20, 2023 | frontiersin.org | Francesco Pepe |Caterina de Luca |Baohua Sun |Kelly M. R

IntroductionLung cancer is one of the leading causes of cancer-related deaths in the world. (1) In the current era of precision medicine, non-small cell lung cancer (NSCLC) has a wide assortment of targeted therapies linked to genomic biomarkers and signatures. (2, 3) Progress in genomic analysis using next-generation sequencing (NGS) has enabled the comprehensive detection of multiple targetable alterations simultaneously from limited tumor tissue.